The quest for the perfect pair of sandals ends here. From fisherman sandals to sturdy flatforms, there’s a sandal type to ...

Ecco has been working for the past few years with up and coming and elite designers to attract younger and fashion-forward ...

Dress shirts and pants roll up nicely and stay ... been forced to pay an additional $100 luggage fee. 15.Teva sandals crafted ...

Women’s maxi dress – I quite liked having a longer item or two ... There are a few different styles to choose from too. Teva trekking sandals – Really durable, great for travel, easy to take on and ...

For Men – Whether you’re a hiker, runner, or just out for a walk, these New Balance Men’s Running Shoes are perfect for everyday activities. For Women – These Teva’s are comfortable ... it’s always ...

Teva Hit With €463 Million EU Fine for Talking Down Rivals EU says Israeli firm thwarted competition for MS drug Teva vows to appeal decision, says it is ‘deeply dissapointed’ ...

JERUSALEM, Nov 6 (Reuters) - Teva Pharmaceutical Industries (TEVA.TA), opens new tab raised its 2024 revenue and earnings guidance on Wednesday after beating third-quarter profit forecasts ...

Wednesday, Teva revealed booming third-quarter sales for its generics and biosimilars. In the U.S., revenue from the knockoffs came in at $1.1 billion, which was a 30% increase year over year, or ...

The European Commission has fined Israeli drugmaker Teva Pharmaceutical Industries (NYSE:TEVA) EUR 462.6M, or around $500M, for trying to ward off competition for its blockbuster multiple ...

European Union antitrust authorities fined Israel’s Teva Pharmaceuticals TEVA1.92%increase; green up pointing triangle 462.6 million euros ($502.3 million), saying the company abused its market ...

Oct. 31 (UPI) --The European Commission fined Teva Pharmaceuticals $503 million for delaying competition posed by rival generic drugmakers, the company's second major financial penalty this month.

BRUSSELS (AP) — The European Commission said Thursday it has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking to protect the patent for its ...